LifeMD (NASDAQ: LFMD), a leading direct-to-patient telehealth
company, announced today it's been ranked 166 on the Deloitte
Technology Fast 500™, a prestigious ranking of the fastest-growing
technology, media, telecommunications, life sciences, fintech and
energy tech companies in North America.
LifeMD experienced remarkable growth during the ranking period
(2019 to 2022), achieving 855% revenue growth. This achievement can
be attributed to LifeMD’s differentiated, end-to-end care platform
and affiliated medical group that has supported the launch of
complex virtual primary care services, such as the LifeMD Weight
Management Program, according to LIfeMD’s Chief Executive Officer
Justin Schrieber.
Schreiber stated, “Our recognition on the Deloitte Technology
Fast 500™, now for the fourth time, is a testament to the
unwavering dedication of our LifeMD team, as well as our commitment
to helping Americans get the quality healthcare they need,
affordably and conveniently. As we continue to grow and expand our
reach, the team has worked hard to stay focused on this mission. We
are proud of this achievement as it is a reflection of our
collective passion that has had a lasting impact on the lives of
our patients.”
The Deloitte Technology Fast 500™ is now in its 29th year and
showcases the progress and innovation of companies in various
industries.
“Each year we look forward to reviewing the progress and
innovations of our Technology Fast 500 winners. This year is
especially celebratory as we expand the number of winners to better
represent just how many companies are developing new ideas to
progress our society and the world, especially during a slow
economy,” said Paul Silverglate, vice chair, Deloitte LLP and
U.S. technology sector leader. “While software and services and
life sciences continue to dominate the top 10, we are encouraged to
see other categories making their mark. Congratulations to all the
winners who show us how creativity, hard work and perseverance can
lead to success.”
“As for growing companies, it’s always rewarding to be
recognized for the ongoing commitment it takes to navigate
obstacles, transform when necessary and ultimately create a
thriving business,” said Christie Simons, partner, Deloitte
& Touche LLP and industry leader for technology, media, and
telecommunications within Deloitte’s audit and assurance practice.
“Over the nearly 30 years we’ve been compiling the Technology Fast
500, we’ve seen new categories emerge, growth rates explode, and
certain regional markets shine from the bright talent they attract.
We are proud of all the winners for achieving this well-deserved
honor.”
LifeMD previously ranked #164, #189, and #140 on Deloitte’s
Technology Fast 500™ in 2018, 2019, and 2022, respectively.
Overall, the 2023 Technology Fast 500 companies achieved revenue
growth ranging from 201% to 222,189% over the three-year time frame
from 2019 to 2022, with an average growth rate of 1,934% and a
median growth rate of 497%.
About the 2023 Deloitte Technology Fast 500Now
in its 29th year, the Deloitte Technology Fast 500 provides a
ranking of the fastest-growing technology, media,
telecommunications, life sciences, fintech, and energy tech
companies — both public and private — in North America. Technology
Fast 500 award winners are selected based on percentage fiscal year
revenue growth from 2019 to 2022.
To be eligible for Technology Fast 500 recognition, companies
must own proprietary intellectual property or technology that is
sold to customers in products that contribute to a majority of the
company’s operating revenues. Companies must have base-year
operating revenues of at least US$50,000, and current-year
operating revenues of at least US$5 million. Additionally,
companies must be in business for a minimum of four years and be
headquartered within North America.
About DeloitteDeloitte provides
industry-leading audit, consulting, tax and advisory services to
many of the world’s most admired brands, including nearly 90% of
the Fortune 500® and more than 8,500 U.S.-based private companies.
At Deloitte, we strive to live our purpose of making an impact
that matters by creating trust and confidence in a more equitable
society. We leverage our unique blend of business acumen, command
of technology, and strategic technology alliances to advise our
clients across industries as they build their future. Deloitte
is proud to be part of the largest global professional services
network serving our clients in the markets that are most important
to them. Bringing more than 175 years of service, our network of
member firms spans more than 150 countries and territories. Learn
how Deloitte’s approximately 457,000 people worldwide connect for
impact at www.deloitte.com.
About LifeMDLifeMD is a leading provider of
virtual primary care. LifeMD offers telemedicine, laboratory and
pharmacy services, and specialized treatment across more than 200
conditions, including primary care, men’s health, women’s health,
allergy & asthma, and dermatology. Leveraging a
vertically-integrated, proprietary digital care platform, a
50-state affiliated medical group, and a US-based patient care
center, LifeMD is elevating healthcare by increasing access to
top-notch and affordable care. For more information, please visit
LifeMD.com.
Cautionary Note Regarding Forward Looking
StatementsDeloitte refers to one or more of Deloitte
Touche Tohmatsu Limited, a UK private company limited by guarantee
(“DTTL”), its network of member firms, and their related entities.
DTTL and each of its member firms are legally separate and
independent entities. DTTL (also referred to as “Deloitte Global”)
does not provide services to clients. In the United States,
Deloitte refers to one or more of the US member firms of DTTL,
their related entities that operate using the “Deloitte” name in
the United States and their respective affiliates. Certain services
may not be available to attest clients under the rules and
regulations of public accounting. Please see www.deloitte.com/about
to learn more about our global network of member firms.
This news release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended;
Section 21E of the Securities Exchange Act of 1934, as amended; and
the safe harbor provision of the U.S. Private Securities Litigation
Reform Act of 1995. Forward-looking statements contained in this
news release may be identified by the use of words such as:
“believe,” “expect,” “anticipate,” “project,” “should,” “plan,”
“will,” “may,” “intend,” “estimate,” predict,” “continue,” and
“potential,” or, in each case, their negative or other variations
or comparable terminology referencing future periods. Examples of
forward-looking statements include, but are not limited to,
statements regarding our financial outlook and guidance, short and
long-term business performance and operations, future revenues and
earnings, regulatory developments, legal events or outcomes,
ability to comply with complex and evolving regulations, market
conditions and trends, new or expanded products and offerings,
growth strategies, underlying assumptions, and the effects of any
of the foregoing on our future results of operations or financial
condition.
Forward-looking statements are not historical facts and are not
assurances of future performance. Rather, these statements are
based on our current expectations, beliefs, and assumptions
regarding future plans and strategies, projections, anticipated and
unanticipated events and trends, the economy, and other future
conditions, including the impact of any of the aforementioned on
our future business. As forward-looking statements relate to the
future, they are subject to inherent risk, uncertainties, and
changes in circumstances and assumptions that are difficult to
predict, including some of which are out of our control.
Consequently, our actual results, performance, and financial
condition may differ materially from those indicated in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, “Risk Factors” identified in our filings
with the Securities and Exchange Commission, including, but not
limited to, our most recently filed Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and any amendments thereto. Even if
our actual results, performance, or financial condition are
consistent with forward-looking statements contained in such
filings, they may not be indicative of our actual results,
performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based
on information currently available to us as of the date on which
this release is made. We undertake no obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise, except as may be required
under applicable law or regulation.
Media Contact:Jessica Friedeman, Chief
Marketing Officerpress@lifemd.com
LifeMD (NASDAQ:LFMDP)
Historical Stock Chart
From May 2024 to Jun 2024
LifeMD (NASDAQ:LFMDP)
Historical Stock Chart
From Jun 2023 to Jun 2024